Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Ketones Stories

2014-04-16 16:30:50

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/q7jzmk/sustained_release) has announced the addition of the "Concise Analysis of International Sustained Release Injectables to 2020" [http://www.researchandmarkets.com/research/q7jzmk/sustained_release ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Formulations, Dosing, Devices, Markets and Forecasts The ability...

2014-04-16 16:23:05

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/xhs2p5/methyl_ethyl) has announced the addition of the "Methyl Ethyl Ketone (MEK): 2014 World Market Outlook and Forecast up to 2018" [http://www.researchandmarkets.com/research/xhs2p5/methyl_ethyl ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Methyl ethyl ketone 2014 World Market Outlook and Forecast is an...

2014-04-16 12:17:44

Floods and droughts are increasingly in the news, and climate experts say their frequency will only go up in the future. As such, it is crucial for scientists to learn more about how these extreme events affect plants in order to prepare for and combat the risks to food security that could result. Like animals, plants have hormones that send chemical signals between its cells relaying information about the plant's development or interactions with the outside world. One particular way in...

2014-04-15 23:12:11

Achieve is conducting a randomized, active and placebo-controlled study to evaluate the efficacy and safety of an experimental drug for preventing flares and reducing serum uric acid in patients with gout. Birmingham, AL (PRWEB) April 15, 2014 *To see if you qualify for this Gout Clinical Trial in Birmingham, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and...

2014-04-15 16:28:26

SAN DIEGO, April 15, 2014 /PRNewswire/ -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today announced that the U.S. District Court in Massachusetts entered an order, preventing the implementation of the Commonwealth's ban of Zohydro(TM) ER on Constitutional grounds. This order will become effective on April 22, 2014. The court decision today supports the...

2014-04-11 08:24:52

SAN DIEGO, April 11, 2014 /PRNewswire/ -- Rampant misinformation about Zohydro(TM) ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals. These inaccurate and misleading statements are often made without proper context, and are intended to be sensational, to create fear, or to generate headlines. In many instances, these statements are not supported by scientific facts or medical evidence. Let's get the facts straight Zohydro ER is the first and...

2014-04-09 23:23:34

The auto-injector is designed to allow quick administration when drug overdose first occurs. LOS ANGELES, CA (PRWEB) April 09, 2014 Family members and caregivers of individuals with opiate drug addiction problems heaved a sigh of relief earlier this month when the FDA announced it was issuing fast-track approval to Evzio (naloxone hydrochloride), an injectable medication that can be administered to someone who is known or suspected to have had an overdose of opioid drugs. The drug will be...

2014-04-09 16:25:15

Part One: "Treating Pain in Today's World: Avoiding the New Pitfalls" LOS ANGELES, April 9, 2014 /PRNewswire/ -- The Cooperative of American Physicians, Inc. (CAP) and The Orange County Medical Association (OCMA) are joint sponsors of "Treating Pain in Today's World: Avoiding the New Pitfalls," the first topic in a three part continuing medical education (CME) series on opioid education. This topic will be presented on Monday, May 5, 2014 at 6 p.m. PT at the Orange County Medical Association...

2014-04-08 20:21:36

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the U.S. Food and Drug Administration (FDA)-approved prescription drug product, Zohydro(TM) ER (hydrocodone bitartrate) extended-release capsules (CII), entered on March 27, 2014, by Massachusetts Governor Deval Patrick. Zogenix appreciates the opportunity to be heard by the court on an expedited basis. A follow-up hearing has been...

2014-04-08 08:33:01

The auto-injector is designed to allow quick administration when drug overdose first occurs LOS ANGELES, April 8, 2014 /PRNewswire/ -- Family members and caregivers of individuals with opiate drug addiction problems heaved a sigh of relief earlier this month when the FDA announced it was issuing fast-track approval to Evzio (naloxone hydrochloride), an injectable medication that can be administered to someone who is known or suspected to have had an overdose of opioid drugs. The drug...